Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Infection and Immunity
|
October 1, 1994
Mycoplasma arginini TUH-14 membrane lipoproteins induce production of interleukin-1, interleukin-6, and tumor necrosis factor alpha by human monocytes
A Herbelin, E Ruuth, D Delorme, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1982
B-cell growth factor: distinction from T-cell growth factor and B-cell maturation factor
T Leanderson, E Lundgren, E Ruuth, et al.
Infection
|
December 13, 2002
Efficacy and tolerability of once-daily telithromycin compared with high-dose amoxicillin for treatment of community-acquired pneumonia
L Hagberg, A Torres, D van Rensburg, et al.
Scandinavian Journal of Immunology
|
June 1, 1985
Mycoplasma mimicry of lymphokine activity in T-cell lines
E Ruuth, M Rånby, B Friedrich, et al.
European Cytokine Network
|
June 12, 2001
Inflammatory cytokine production in interferon-gamma-primed mice, challenged with lipopolysaccharide. Inhibition by SK&F 86002 and interleukin-1 beta-converting enzyme inhibitor
S Spinelle-Jaegle, P Devillier, S Doucet, et al.
Scandinavian Journal of Immunology
|
July 9, 2002
In vitro and in Vivo inhibition of immunoglobulin secretion by the immunosuppressive compound HR325 is reversed by exogenous uridine
T A Thomson, S Spinella-Jaegle, E Francesconi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1997
Potencies of leflunomide and HR325 as inhibitors of prostaglandin endoperoxide H synthase-1 and -2: comparison with nonsteroidal anti-inflammatory drugs
A P Curnock, P A Robson, C M Yea, et al.
The Biochemical Journal
|
November 20, 1998
Purification of human dihydro-orotate dehydrogenase and its inhibition by A77 1726, the active metabolite of leflunomide
J M Bruneau, C M Yea, S Spinella-Jaegle, et al.
The Journal of Biological Chemistry
|
September 22, 1995
Dihydroorotate dehydrogenase is a high affinity binding protein for A77 1726 and mediator of a range of biological effects of the immunomodulatory compound
R A Williamson, C M Yea, P A Robson, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Infection and Immunity
|
October 1, 1994
Mycoplasma arginini TUH-14 membrane lipoproteins induce production of interleukin-1, interleukin-6, and tumor necrosis factor alpha by human monocytes
A Herbelin, E Ruuth, D Delorme, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1982
B-cell growth factor: distinction from T-cell growth factor and B-cell maturation factor
T Leanderson, E Lundgren, E Ruuth, et al.
Infection
|
December 13, 2002
Efficacy and tolerability of once-daily telithromycin compared with high-dose amoxicillin for treatment of community-acquired pneumonia
L Hagberg, A Torres, D van Rensburg, et al.
Scandinavian Journal of Immunology
|
June 1, 1985
Mycoplasma mimicry of lymphokine activity in T-cell lines
E Ruuth, M Rånby, B Friedrich, et al.
European Cytokine Network
|
June 12, 2001
Inflammatory cytokine production in interferon-gamma-primed mice, challenged with lipopolysaccharide. Inhibition by SK&F 86002 and interleukin-1 beta-converting enzyme inhibitor
S Spinelle-Jaegle, P Devillier, S Doucet, et al.
Scandinavian Journal of Immunology
|
July 9, 2002
In vitro and in Vivo inhibition of immunoglobulin secretion by the immunosuppressive compound HR325 is reversed by exogenous uridine
T A Thomson, S Spinella-Jaegle, E Francesconi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1997
Potencies of leflunomide and HR325 as inhibitors of prostaglandin endoperoxide H synthase-1 and -2: comparison with nonsteroidal anti-inflammatory drugs
A P Curnock, P A Robson, C M Yea, et al.
The Biochemical Journal
|
November 20, 1998
Purification of human dihydro-orotate dehydrogenase and its inhibition by A77 1726, the active metabolite of leflunomide
J M Bruneau, C M Yea, S Spinella-Jaegle, et al.
The Journal of Biological Chemistry
|
September 22, 1995
Dihydroorotate dehydrogenase is a high affinity binding protein for A77 1726 and mediator of a range of biological effects of the immunomodulatory compound
R A Williamson, C M Yea, P A Robson, et al.
Page
of 2